UPDATE: Morgan Stanley Initiates Timken As Equal-Weight With A $54 Target As Firm Believes 'TKR shares trade at a discount to short cycle peers, yet its Process business (50% of sales; 2/3rds of EBIT) is longer-cycle and less vulnerable'